$PNPL
Pineapple Inc

2023 Q1 Form 10-Q Financial Statement

#000149315223000627 Filed on January 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q3 2021 Q3
Revenue $45.60K
YoY Change
Cost Of Revenue $268.00
YoY Change
Gross Profit $63.00
YoY Change
Gross Profit Margin
Selling, General & Admin $111.6K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.541K $933.00 $1.541K
YoY Change -3.69% -39.45%
% of Gross Profit 1480.95%
Operating Expenses $113.1K $126.0K $128.6K
YoY Change -12.26% -1.98%
Operating Profit -$67.52K -$126.0K -$128.6K
YoY Change -47.63% -1.98%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$9.643M -$227.8K
YoY Change 4132.85%
Pretax Income -$67.52K -$9.769M -$356.4K
YoY Change -117.99% 2641.18%
Income Tax
% Of Pretax Income
Net Earnings -$67.52K -$9.769M -$356.4K
YoY Change -117.99% 2641.18%
Net Earnings / Revenue -148.07%
Basic Earnings Per Share $0.00 -$0.11 $0.00
Diluted Earnings Per Share $0.00 -$0.11
COMMON SHARES
Basic Shares Outstanding 91.16M shares 91.16M shares 89.70M shares
Diluted Shares Outstanding 91.16M shares

Balance Sheet

Concept 2023 Q1 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents
Short-Term Investments $0.00
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $5.000K
Receivables
Other Receivables
Total Short-Term Assets $50.60K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $817.00 $4.395K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $622.4K $4.395K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $50.60K
Total Long-Term Assets $622.4K $4.395K
Total Assets $673.0K $4.395K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.50K $414.6K
YoY Change
Accrued Expenses $6.770K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $783.6K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.635M $2.779M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.635M $2.779M
Total Long-Term Liabilities $0.00
Total Liabilities $2.115M $2.779M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$23.60M -$24.93M
YoY Change
Common Stock $7.00 $9.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.442M -$2.775M $5.771M
YoY Change
Total Liabilities & Shareholders Equity $673.0K $4.395K
YoY Change

Cashflow Statement

Concept 2023 Q1 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$67.52K -$9.769M -$356.4K
YoY Change -117.99% 2641.18%
Depreciation, Depletion And Amortization $1.541K $933.00 $1.541K
YoY Change -3.69% -39.45%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Assets Current
AssetsCurrent
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Cash
Cash
usd
CY2022Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 PNPL Stock Payable
StockPayable
usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2021Q3 PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
usd
PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
usd
us-gaap Stock Issued1
StockIssued1
usd
PNPL Gain On Forgiveness Of Related Party Note Payable
GainOnForgivenessOfRelatedPartyNotePayable
usd
PNPL Deposit On Stock Purchase Agreement
DepositOnStockPurchaseAgreement
usd
PNPL Gain Loss On Impairment Of Equitymethod Investment
GainLossOnImpairmentOfEquitymethodInvestment
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
PNPL Termination Of Stock Purchase Agreement
TerminationOfStockPurchaseAgreement
usd
dei Document Type
DocumentType
10-Q
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
usd
PNPL Gain Loss On Impairment Of Equitymethod Investment
GainLossOnImpairmentOfEquitymethodInvestment
usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
usd
CY2021Q3 PNPL Gain Loss On Impairment Of Equitymethod Investment
GainLossOnImpairmentOfEquitymethodInvestment
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001654672
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q3 us-gaap Cash
Cash
usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q3 PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
usd
CY2021Q3 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55896
dei Entity Registrant Name
EntityRegistrantName
PINEAPPLE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5185484
dei Entity Address Address Line1
EntityAddressAddressLine1
10351 Santa Monica Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 420
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90025
dei City Area Code
CityAreaCode
877
dei Local Phone Number
LocalPhoneNumber
310-7675
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
91163569 shares
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
100000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
100000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4395 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8524 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
9288298 usd
CY2022Q3 us-gaap Assets
Assets
4395 usd
CY2021Q4 us-gaap Assets
Assets
9396822 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
367124 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
715546 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
47500 usd
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
16500 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
6771 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
6771 usd
CY2022Q3 PNPL Settlement Payable Related Party Current
SettlementPayableRelatedPartyCurrent
615000 usd
CY2021Q4 PNPL Settlement Payable Related Party Current
SettlementPayableRelatedPartyCurrent
615000 usd
CY2022Q3 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
684817 usd
CY2021Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
529948 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
763739 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
886918 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
19838 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
19838 usd
CY2022Q3 PNPL Advance On Agreements Current
AdvanceOnAgreementsCurrent
169000 usd
CY2021Q4 PNPL Advance On Agreements Current
AdvanceOnAgreementsCurrent
169000 usd
CY2022Q3 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
105523 usd
CY2021Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
105523 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2779311 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3065044 usd
CY2022Q3 us-gaap Liabilities
Liabilities
2779311 usd
CY2021Q4 us-gaap Liabilities
Liabilities
3065044 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0000001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0000001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91163569 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91163569 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91163569 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91163569 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
9 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
9 usd
CY2022Q3 PNPL Stock Payable
StockPayable
150000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22004077 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22004077 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24929002 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15672308 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-2774916 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6331778 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4395 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9396822 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
125090 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
127031 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
380553 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
448030 usd
CY2022Q3 us-gaap Depreciation
Depreciation
933 usd
CY2021Q3 us-gaap Depreciation
Depreciation
1541 usd
us-gaap Depreciation
Depreciation
4129 usd
us-gaap Depreciation
Depreciation
4623 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
126023 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
128572 usd
us-gaap Operating Expenses
OperatingExpenses
384682 usd
us-gaap Operating Expenses
OperatingExpenses
452653 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-126023 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-128572 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-384682 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-452653 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
757991 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-227822 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1499355 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-790126 usd
PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
30000 usd
CY2022Q3 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
386287 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
386287 usd
CY2022Q3 PNPL Gain Loss On Impairment Of Equitymethod Investment
GainLossOnImpairmentOfEquitymethodInvestment
-10787652 usd
PNPL Gain Loss On Impairment Of Equitymethod Investment
GainLossOnImpairmentOfEquitymethodInvestment
-10787652 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9643374 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-227822 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8872010 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-790126 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9769397 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-356394 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9256692 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1242779 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9769397 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-356394 usd
us-gaap Net Income Loss
NetIncomeLoss
-9256692 usd
us-gaap Net Income Loss
NetIncomeLoss
-1242779 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91163569 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89695191 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91163569 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88951234 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6331778 usd
CY2022Q1 PNPL Stock Issued During Period Value Common Stock Subscription Received
StockIssuedDuringPeriodValueCommonStockSubscriptionReceived
100000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
375215 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
6806993 usd
CY2022Q2 PNPL Stock Issued During Period Value Common Stock Subscription Received
StockIssuedDuringPeriodValueCommonStockSubscriptionReceived
50000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
137488 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6994481 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9769397 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-2774916 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
6729597 usd
CY2021Q1 PNPL Stock Issued During Period Value Common Stock Subscription Received
StockIssuedDuringPeriodValueCommonStockSubscriptionReceived
147000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-409430 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
6467167 usd
CY2021Q2 PNPL Stock Issued During Period Value Common Stock Subscription Received
StockIssuedDuringPeriodValueCommonStockSubscriptionReceived
35000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
102000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-476955 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
6127212 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-356394 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-356394 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
5770818 usd
us-gaap Net Income Loss
NetIncomeLoss
-9256692 usd
us-gaap Net Income Loss
NetIncomeLoss
-1242779 usd
us-gaap Depreciation
Depreciation
4129 usd
us-gaap Depreciation
Depreciation
4623 usd
us-gaap Share Based Compensation
ShareBasedCompensation
35000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1499355 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-790126 usd
PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
30000 usd
PNPL Gain Loss On Impairment Of Equitymethod Investment
GainLossOnImpairmentOfEquitymethodInvestment
-10787652 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
386287 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
90800 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-46397 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
31000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
126481 usd
us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
154868 usd
us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
271571 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-103885 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-61375 usd
PNPL Proceeds From Stock Subscription Received
ProceedsFromStockSubscriptionReceived
150000 usd
PNPL Proceeds From Stock Subscription Received
ProceedsFromStockSubscriptionReceived
249000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5885 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
56325 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
52000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
243950 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
103885 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
61375 usd
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
62935 usd
us-gaap Stock Issued1
StockIssued1
35000 usd
PNPL Gain On Forgiveness Of Related Party Note Payable
GainOnForgivenessOfRelatedPartyNotePayable
30000 usd
PNPL Deposit On Stock Purchase Agreement
DepositOnStockPurchaseAgreement
100000 usd
PNPL Termination Of Stock Purchase Agreement
TerminationOfStockPurchaseAgreement
100000 usd
PNPL Non Cash Gain On Sale Of Subsidiary
NonCashGainOnSaleOfSubsidiary
386287 usd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
1983-08-03
CY2022Q3 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
10000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
376287 usd
CY2022Q3 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
10000 usd
CY2022Q3 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
386287 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
386287 usd
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2500000 shares
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zEjlfAIUUUXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zkTh1GalObof">Use of Estimates in Financial Reporting</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the recoverability and useful lives of long-lived assets, assessment of legal accruals, the fair value of the Company’s stock, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 PNPL Shares Issuable For Conversion Of Notes Payable
SharesIssuableForConversionOfNotesPayable
0 shares
CY2021Q4 PNPL Shares Issuable For Conversion Of Notes Payable
SharesIssuableForConversionOfNotesPayable
0 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2022Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
11000000 usd
CY2022Q3 PNPL Investment Owned Subject To Option Exercise Price
InvestmentOwnedSubjectToOptionExercisePrice
0.55
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24929002 usd
us-gaap Net Income Loss
NetIncomeLoss
-9256692 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-103885 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
150000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55473 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55473 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
51078 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
46949 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4395 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8524 usd
CY2022Q3 us-gaap Depreciation
Depreciation
933 usd
us-gaap Depreciation
Depreciation
4129 usd
CY2021Q3 us-gaap Depreciation
Depreciation
1541 usd
us-gaap Depreciation
Depreciation
4623 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1499355 usd
PNPL Gain Loss On Impairment Of Equitymethod Investment
GainLossOnImpairmentOfEquitymethodInvestment
-10787652 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
763739 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
886918 usd
CY2022Q3 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
615000 usd
CY2021Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
615000 usd
CY2022Q3 PNPL Advances On Agreements Current
AdvancesOnAgreementsCurrent
169000 usd
CY2021Q4 PNPL Advances On Agreements Current
AdvancesOnAgreementsCurrent
169000 usd
us-gaap Payments For Rent
PaymentsForRent
3750 usd
CY2022Q3 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
525000000 shares
CY2022Q3 PNPL Capital Stock Par Value
CapitalStockParValue
0.0000001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91163569 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91163569 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91163569 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91163569 shares
CY2021Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
2490000 shares
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
2490000 shares
CY2021Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
249000 usd
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
249000 usd
us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
1829631 shares
CY2022Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
150000 usd
CY2022Q1 PNPL Common Stock Share Subscribed But Unissued Subscriptions Receivable Shares
CommonStockShareSubscribedButUnissuedSubscriptionsReceivableShares
400000 shares
CY2022Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.25
CY2022Q2 PNPL Common Stock Share Subscribed But Unissued Subscriptions Receivable Shares
CommonStockShareSubscribedButUnissuedSubscriptionsReceivableShares
100000 shares
CY2022Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.50
CY2022Q3 us-gaap Preferred Stock Shares Subscribed But Unissued Value
PreferredStockSharesSubscribedButUnissuedValue
150000 usd

Files In Submission

Name View Source Status
0001493152-23-000627-index-headers.html Edgar Link pending
0001493152-23-000627-index.html Edgar Link pending
0001493152-23-000627.txt Edgar Link pending
0001493152-23-000627-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
pnpl-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
pnpl-20220930_lab.xml Edgar Link unprocessable
pnpl-20220930_pre.xml Edgar Link unprocessable
pnpl-20220930_cal.xml Edgar Link unprocessable
pnpl-20220930_def.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable